Phase 1 study of ceritinib in pediatric patients with malignancies harboring activated anaplastic lymphoma kinase (ALK): Safety, pharmacokinetics and efficacy results from the fed population Meeting Abstract
| Authors: | Fischer, M.; Wulff, B.; Baruchel, S.; Berlanga, P.; Trahair, T.; Mechinaud, F.; Schulte, J.; Modak, S.; Merks, J. H.; Zwaan, C. M.; Marshall, L. V.; Casanova, M.; Branle, F.; Malet, I.; Emeremni, A. C.; Geoerger, B. |
| Abstract Title: | Phase 1 study of ceritinib in pediatric patients with malignancies harboring activated anaplastic lymphoma kinase (ALK): Safety, pharmacokinetics and efficacy results from the fed population |
| Meeting Title: | 28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics |
| Journal Title: | European Journal of Cancer |
| Volume: | 69 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2016 Nov 29-Dec 2 |
| Meeting Location: | Munich, Germany |
| ISSN: | 0959-8049 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2016-12-01 |
| Start Page: | S49 |
| End Page: | S50 |
| Language: | English |
| ACCESSION: | WOS:000390503500127 |
| PROVIDER: | wos |
| DOI: | 10.1016/S0959-8049(16)32732-0 |
| Notes: | Meeting Abstract: 133 -- 28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics -- NOV 29-DEC 02, 2016 -- Munich, GERMANY -- Source: Wos |
